Format

Send to

Choose Destination
J Allergy Clin Immunol. 2015 Sep;136(3):797-800. doi: 10.1016/j.jaci.2015.02.018. Epub 2015 Apr 2.

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma.

Author information

1
Sterna Biologicals GmbH, Marburg, Germany.
2
Institute of Laboratory Medicine and Pathobiochemistry-Molecular Diagnostics, Medical Faculty, Philipps University Marburg, Universities of Giessen and Marburg Lung Center (UGMLC), Marburg, Germany.
3
Private Consultant, Munich, Germany.
4
Department of Clinical Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
5
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.
6
Engelhard Arzneimittel GmbH, Niederdorfelden, Germany.
7
Vectura GmbH, Gauting, Germany.
8
AccelPharm, Basel, Switzerland.
9
Private Consultant, Wuppertal, Germany.
10
Institute of Laboratory Medicine and Pathobiochemistry-Molecular Diagnostics, Medical Faculty, Philipps University Marburg, Universities of Giessen and Marburg Lung Center (UGMLC), Marburg, Germany. Electronic address: garn@staff.uni-marburg.de.
PMID:
25842286
DOI:
10.1016/j.jaci.2015.02.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center